Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

APASL clinical practice guidance: the diagnosis and management of patients with Wilson's disease.

Hepatology international·2026

Same author

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update.

Hepatology international·2026

Same author

Development and validation of a nomogram for predicting 30-day mortality in DBV-induced sepsis with pancreatic injury.

iScience·2026

Same author

Single-cell Sequencing Reveals Neutrophil Extracellular Traps in Association with Endotheliopathy and Immunothrombosis in Hepatitis B Virus-related Acute-on-chronic Liver Failure.

Journal of clinical and translational hepatology·2026

Same author

FGL2-HDAC11 Drives Immunothrombosis via NETs-Mediated Endothelial Capillarization in MASLD Fibrosis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Fibrinogen-Like Protein 2 Modulates B Cell Mucosal Immunity by Suppressing Receptor for Activated C-Kinase 1-Mediated AKT Phosphorylation.

MedComm·2026

Same journal

Prevention of cognitive decline and dementia: Current evidence on lifestyle factors and dietary patterns.

EXCLI journal·2026

Same journal

Bidirectional relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

EXCLI journal·2026

Same journal

Triterpenoid saponins and ferroptosis: A membrane centered perspective.

EXCLI journal·2026

Same journal

Picroside III: novel multifunctional iridoid glycoside with promising antileukemic activity.

EXCLI journal·2026

Same journal

Nanotechnology-driven delivery of dexamethasone for arthritis: The role of liposomes.

EXCLI journal·2026

Same journal

Malnutrition-Sarcopenia Syndrome in older adults: Causes, consequences, and countermeasures.

EXCLI journal·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 1, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Immune mediated liver failure.

Xiaojing Wang¹, Qin Ning¹

¹Department and Institute of Infectious Disease, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China.

|September 30, 2015

Summary

This summary is machine-generated.

Immune-mediated liver injury is crucial in liver failure pathogenesis. This review explores innate and adaptive immunity mechanisms, including immune coagulation, in liver failure progression.

Keywords:

adaptive immunity cytokines humoral immunity immune innate immunity liver failure

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Related Experiment Videos

Last Updated: Apr 1, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Area of Science:

Hepatology
Immunology
Pathophysiology

Background:

Liver failure is a critical syndrome characterized by jaundice, encephalopathy, and coagulopathy, leading to multiorgan failure.
Massive hepatocyte death exceeding liver regeneration capacity is the central event in liver failure.
Both direct damage and immune-mediated liver injury contribute to hepatocyte death, with growing evidence highlighting the latter's significance.

Purpose of the Study:

To review current understanding of immune-mediated liver injury mechanisms in liver failure.
To discuss the roles of innate and adaptive immunity in liver failure pathogenesis.
To highlight the concept of immune coagulation in liver disease progression.

Main Methods:

Review of human and animal studies on liver failure.
Analysis of immune cell and molecule interactions.
Examination of death receptor signaling pathways.

Main Results:

Immune-mediated liver injury plays a key role in liver failure development.
Both innate and adaptive immune responses are involved.
Immune coagulation is linked to disease progression, particularly in HBV-related acute-on-chronic liver failure.

Conclusions:

Immune-mediated liver injury is a critical determinant of liver failure.
Understanding immune cell interactions and signaling pathways is vital for therapeutic strategies.
The concept of immune coagulation offers insights into disease exacerbation.